Patents by Inventor Ozge BOYACIOGLU

Ozge BOYACIOGLU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260144766
    Abstract: The non-small cell lung cancer adenocarcinoma via the pathway mediated with the cannabinoid receptor is targeted for the first time with the synthetic cannabinoid agonist arachidonoyl cyclopropylamide (ACPA). An ACPA-PCL nanoparticle release system based on nanoengineering provides long term-controlled release and stability of the CB1 receptor agonist ACPA following the determination of the efficient dose and the antiproliferative effect of ACPA on the non-small cell lung cancer lines expressing the cannabinoid (CB) receptors in vitro medium at different doses.
    Type: Application
    Filed: October 24, 2025
    Publication date: May 28, 2026
    Applicants: HACETTEPE UNIVERSITESI, ATILIM UNIVERSITESI
    Inventors: Ozge BOYACIOGLU, Petek KORKUSUZ, Elif BILGIC, Erem BILENSOY, Cem VARAN, Emirhan NEMUTLU
  • Publication number: 20220168245
    Abstract: The non-small cell lung cancer adenocarcinoma via the pathway mediated with the cannabinoid receptor is targeted for the first time with the synthetic cannabinoid agonist arachidonoyl cyclopropylamide (ACPA). An ACPA-PCL nanoparticle release system based on nanoengineering provides long term-controlled release and stability of the CB1 receptor agonist ACPA following the determination of the efficient dose and the antiproliferative effect of ACPA on the non-small cell lung cancer lines expressing the cannabinoid (CB) receptors in vitro medium at different doses.
    Type: Application
    Filed: July 13, 2020
    Publication date: June 2, 2022
    Applicants: HACETTEPE UNIVERSITESI, ATILIM UNIVERSITESI
    Inventors: Ozge BOYACIOGLU, Petek KORKUSUZ, Elif BILGIC, Erem BILENSOY, Cem VARAN, Emirhan NEMUTLU